Cargando…

Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020

This cross-sectional study examines trends in drug spending in Medicare Parts B and D and describes the share of total use and spending attributed to oncology drugs within each program.

Detalles Bibliográficos
Autores principales: Kyle, Michael Anne, Dusetzina, Stacie B., Keating, Nancy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280395/
https://www.ncbi.nlm.nih.gov/pubmed/35816318
http://dx.doi.org/10.1001/jamanetworkopen.2022.21468
_version_ 1784746633861267456
author Kyle, Michael Anne
Dusetzina, Stacie B.
Keating, Nancy L.
author_facet Kyle, Michael Anne
Dusetzina, Stacie B.
Keating, Nancy L.
author_sort Kyle, Michael Anne
collection PubMed
description This cross-sectional study examines trends in drug spending in Medicare Parts B and D and describes the share of total use and spending attributed to oncology drugs within each program.
format Online
Article
Text
id pubmed-9280395
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-92803952022-08-01 Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020 Kyle, Michael Anne Dusetzina, Stacie B. Keating, Nancy L. JAMA Netw Open Research Letter This cross-sectional study examines trends in drug spending in Medicare Parts B and D and describes the share of total use and spending attributed to oncology drugs within each program. American Medical Association 2022-07-13 /pmc/articles/PMC9280395/ /pubmed/35816318 http://dx.doi.org/10.1001/jamanetworkopen.2022.21468 Text en Copyright 2022 Kyle MA et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Kyle, Michael Anne
Dusetzina, Stacie B.
Keating, Nancy L.
Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
title Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
title_full Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
title_fullStr Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
title_full_unstemmed Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
title_short Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
title_sort evaluation of trends in oncology drug spending in medicare, 2016 to 2020
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280395/
https://www.ncbi.nlm.nih.gov/pubmed/35816318
http://dx.doi.org/10.1001/jamanetworkopen.2022.21468
work_keys_str_mv AT kylemichaelanne evaluationoftrendsinoncologydrugspendinginmedicare2016to2020
AT dusetzinastacieb evaluationoftrendsinoncologydrugspendinginmedicare2016to2020
AT keatingnancyl evaluationoftrendsinoncologydrugspendinginmedicare2016to2020